Notify Therapeutics secures €5M to develop novel hormone-free fertility treatment for women

Funding Rounds

▤ Summary

Copenhagen-based Notify Therapeutics, a “first-in-class” female fertility treatment, announced that it has secured €5M in a fresh round of funding. Notify Therapeutics, an initiative stemming from Professor Karin Lykke-Hartmann’s research on female infertility, aims to address the lack of innovation in this field despite increasing patient needs. Their primary objective is to develop a hormone-free fertility treatment. Lundbeckfonden BioCapital and +ND Capital have jointly invested in the Danish company. The two investors are already partners on the Danish biotech scene, and this new investment underlines Lundbeckfonden BioCapital’s long standing commitment to Danish science and the local biotech ecosystem.

$ Funding

$
Amount - Total raised
□
Date - Announcement date
◎
Investors +ND Capital, Lundbeckfonden Lead investors
▥
Company - Funded company

▥ Classifications

industries
No industries detected
applications
No applications detected

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies